Netherlands· NL-6c1cc2b41566
Detrusitol SR 2 mg, capsules met verlengde afgifte, hard
A tolterodine product containing tolterodinetartraat, registered in Netherlands by Viatris Healthcare Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tolterodine is registered in 16 of 19 countries.
Countries holding a registration under ATC G04BD07 (tolterodine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Tolterodine · ATC G04BD07
16 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tolterodine costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.70 in Italy to $1.95 in Switzerland — a ×2.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tolterodine · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.95
- ES Spain$1.16
- IT Italy$0.70
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TOLTERODINETARTRAAT
- Manufacturer
- Viatris Healthcare Limited
- Country
- Netherlands (NL)
- ATC code
- G04BD07
- ATC class
- Tolterodine
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id26669
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
324 interactions on record for tolterodine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tolterodine · interactions on record
324 records
- 3 severe
- 129 moderate
- 33 minor
- 152 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- ClotrimazoleA01AB18moderate
7 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tolterodine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDetrol LAViatris Specialty LLC
- SwedenDetrusitol SR 2 mg Depotkapsel, hårdViatris Healthcare Limited
- United KingdomMariosea XL 2mg capsulesTeva UK Ltd
- FinlandDetrusitol SrViatris Healthcare Limited
- IrelandDetrusitol SR 2 mg prolonged-release capsules, hardViatris Healthcare Limited
- BelgiumDetrusitol Retard 2 mgViatris Healthcare
- PolandTitlodineFarmak International Sp. z o.o.
- CanadaDETROL LABGP PHARMA ULC
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Detrusitol, Tolterodin Accord
- Belgium · Detrusitol, Detrusitol Retard
- Bulgaria · Толтеродин Акорд
- Cyprus · Detrusitol, Tolterana
- Germany · Detrusitol, Detrusitol Retard
- Denmark · Detrusitol Retard, Tolterodin Rivopharm
- Estonia · Uroflow
- Spain · Detrusitol, Detrusitol Neo
- Finland · Detrusitol, Detrusitol Sr
- France · Detrusitol
- United Kingdom (Northern Ireland) · Blerone Xl, Caristenol
- Greece · Cinterol, Detrusitol
- Ireland · Detrusitol, Detrusitol Sr
- Iceland · Detrusitol Retard, Tolterodin Actavis
- Italy · Detrusitol, Detrusitol Retard
- Lithuania · Detrusitol, Detrusitol Sr
- Luxembourg · Detrusitol, Detrusitol Retard
- Latvia · Uroflow
- Norway · Detrusitol Sr, Tolterodine Sandoz
- Poland · Defur, Titlodine
- Romania · Uroflow
- Sweden · Detrusitol, Detrusitol Sr
- Slovenia · Detrusitol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/24f833bb-330f-45e2-9349-7a582afcebaf GET /v1/drugs/24f833bb-330f-45e2-9349-7a582afcebaf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule met gereguleerde afgifte, hard",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h26669_smpc.pdf",
"strength": null,
"atc_label": "Tolterodine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg26669",
"excipients": [
"ETHYLCELLULOSE (E 462)",
"GELATINE (E 441)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"IJZEROXIDE GEEL (E 172)",
"INDIGOKARMIJN (E 132)",
"MAÏSZETMEEL",
"OLIEZUUR (E 570)",
"PROPYLEENGLYCOL (E 1520)",
"SACCHAROSE",
"SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
"SIMETICON",
"SUIKERZETMEELBOLLETJES",
"TITAANDIOXIDE (E 171)",
"TITAANDIOXIDE (E 171)",
"TRIGLYCERIDEN MIDDELLANGE KETEN",
"WITTE INKT"
],
"substances": [
"TOLTERODINETARTRAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h26669.pdf",
"authorised_at": "2001/09/04",
"procedure_number": "SE/H/0139/003",
"dispensing_status": "Uitsluitend recept",
"registration_number": "26669",
"additional_monitoring": "N"
}See everything about tolterodine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.